Vaccine strategies: selective elicitation of cellular or humoral immunity?

Author： Shearer G.M.   Clerici M.  

Publisher： Elsevier

ISSN： 0167-7799

Source： Trends in Biotechnology, Vol.15, Iss.3, 1997-03, pp. : 106-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microbial pathogen genomes - new strategies for identifying therapeutics and vaccine targets

By Smith D.R.  

Trends in Biotechnology, Vol. 14, Iss. 8, 1996-08 ,pp. : 290-293

Elsevier

Access to resources Recommend Favorite

Building with a scaffold: emerging strategies for high- to low-level cellular modeling

By Ideker T.   Lauffenburger D.  

Trends in Biotechnology, Vol. 21, Iss. 6, 2003-06 ,pp. : 255-262

Elsevier

Access to resources Recommend Favorite

Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53

By Katkoori VR  

Biotechnic & Histochemistry, Vol. 88, Iss. 1, 2013-01 ,pp. : 38-46

Informa Healthcare

Access to resources Recommend Favorite

Vaccine Trials

By Farrington C.P.   Miller E.  

Molecular Biotechnology, Vol. 17, Iss. 1, 2001-01 ,pp. : 43-58

Humana Press, Inc

Access to resources Recommend Favorite

Alzheimers vaccine?

By McKay D.  

Trends in Biotechnology, Vol. 19, Iss. 10, 2001-10 ,pp. : 379-380

Elsevier

Access to resources Recommend Favorite